E. Kubista

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

José Baselga, Peter van Dam, Alexey Manikhas et al. · Journal of Clinical Oncology · 2009 · 658 citations

Medicine, Oncology, Pharmacology +17

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth et al. · The Lancet Oncology · 2008 · 397 citations

Medicine, Oncology, Pharmacotherapy +17

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg et al. · PubMed · 2002 · 387 citations

Medicine, Cancer Biology, Oncology +15

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

Peter Kenemans, N.J. Bundred, Jean-Michel Foidart et al. · The Lancet Oncology · 2009 · 332 citations · Full text

Medicine, Oncology, Pharmacology +10

Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a

R. Jakesz, Richard Greil, Michael Gnant et al. · JNCI Journal of the National Cancer Institute · 2007 · 316 citations

Medicine, Oncology, Pharmacology +14